{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:58:05Z","timestamp":1790697485816,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115351","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:01:54Z","timestamp":1773392514000},"page":"115351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased anti-SARS-CoV-2 antibody titers in plasma-derived intravenous immunoglobulin collected in Southern China"],"prefix":"10.1016","volume":"29","author":[{"given":"Congyan","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115351_bib1","article-title":"Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies","volume":"4","author":"Hadisi","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2026.115351_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.115351_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2020.04.136","article-title":"Biochemical characterization of SARS-CoV-2 nucleocapsid protein","volume":"527","author":"Zeng","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.isci.2026.115351_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.115351_bib5","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1080\/07391102.2020.1861983","article-title":"Structure and dynamics of membrane protein in SARS-CoV-2","volume":"40","author":"Mahtarin","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.isci.2026.115351_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/v15041000","article-title":"The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target","volume":"15","author":"Santos-Mendoza","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115351_bib7","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1002\/mco2.126","article-title":"SARS-CoV-2 Omicron variant: Immune escape and vaccine development","volume":"3","author":"Ao","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.115351_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108299","article-title":"Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4\/5 on Spike function and neutralization","volume":"26","author":"Pastorio","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.115351_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v16040649","article-title":"Characterizing Infections in Two Epidemic Waves of SARS-CoV-2 Omicron Variants: A Cohort Study in Guangzhou, China","volume":"16","author":"Qu","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115351_bib10","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s11845-022-03266-6","article-title":"The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis","volume":"192","author":"Kow","year":"2023","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.isci.2026.115351_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2024.2345968","article-title":"China's policies: post-COVID-19 challenges for the older population","volume":"17","author":"Wei","year":"2024","journal-title":"Glob. Health Action"},{"key":"10.1016\/j.isci.2026.115351_bib12","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115351_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.add4602","article-title":"Vaccinate to combat COVID-19 in China","volume":"377","author":"Chen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115351_bib14","doi-asserted-by":"crossref","DOI":"10.2196\/42671","article-title":"Evolution of Public Attitudes and Opinions Regarding COVID-19 Vaccination During the Vaccine Campaign in China: Year-Long Infodemiology Study of Weibo Posts","volume":"25","author":"Hong","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.isci.2026.115351_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40249-023-01151-7","article-title":"Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero","volume":"12","author":"Rodewald","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.isci.2026.115351_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: A review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2026.115351_bib17","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1002\/mco2.426","article-title":"Blood-derived product therapies for SARS-CoV-2 infection and long COVID","volume":"4","author":"Wu","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.115351_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(21)00755-6","article-title":"Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products-an update","volume":"22","author":"Romero","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115351_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/infdis\/jiab142","article-title":"Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic","volume":"226","author":"Farcet","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115351_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1473-3099(21)00059-1","article-title":"Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products","volume":"21","author":"Romero","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115351_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100826","article-title":"Antibody-receptor interactions mediate antibody-dependent cellular cytotoxicity","volume":"297","author":"Sun","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115351_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.115351_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.fmre.2021.01.011","article-title":"Current progress and challenges in the design and development of a successful COVID-19 vaccine","volume":"1","author":"Li","year":"2021","journal-title":"Fundam. Res."},{"key":"10.1016\/j.isci.2026.115351_bib24","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/ajt.17086","article-title":"Intravenous immunoglobulin contains high-titer neutralizing IgG antibodies to SARS-CoV-2","volume":"22","author":"Jordan","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2026.115351_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-3532-1_1","article-title":"B Cell Development and Maturation","volume":"1254","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.isci.2026.115351_bib26","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2026.115351_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29143","article-title":"CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study","volume":"95","author":"Hu","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2026.115351_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41591-023-02212-y","article-title":"Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022","volume":"29","author":"Leung","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115351_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115351_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115351_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226007261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:02:53Z","timestamp":1790694173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226007261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226007261"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115351","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased anti-SARS-CoV-2 antibody titers in plasma-derived intravenous immunoglobulin collected in Southern China","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115351"}}